A Corporate Tax Dodge Gets Harder - The New York Times:
"Pfizer never tried to hide the fact that its proposed $152 billion merger with Allergan, based in Ireland, would cut its tax bill in the United States. But even as it rushed to complete the biggest tax-avoidance deal in the history of corporate America, it continued to promote the strategic and economic benefits of the merger."
'via Blog this'
No comments:
Post a Comment